SKI Market

Indian Indices

Sensex

83,627.69 -250.48
( -0.30%)

Global Indices

Nasdaq

49,609.72 84.64
(0.17%)

Dow Jones

6,998.08 10.80
(0.15%)

Hang Seng

53,586.32 1,646.43
(3.17%)

Nikkei 225

10,138.60 -2.10
(-0.02%)

Forex

USD-INR

90.22 0.30
(0.34%)

EUR-INR

104.95 0.05
(0.04%)

GBP-INR

120.87 0.01
(0.01%)

JPY-INR

0.57 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Everest Organics Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524790

INE334C01029

74.6694113

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

71.61

473.53

EPS(TTM)

Face Value()

Div & Yield %

6.81

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	182.37	226.49	208.73	230.22	207.36	189.61
Excise Duty	22.89	29.25	25.69	30.17	25.79	22.40
Net Sales	159.48	197.24	183.04	200.05	181.57	167.21
Other Income	0.69	0.89	6.94	2.21	1.06	1.45
Stock Adjustments	-1.04	-0.56	3.23	4.51	8.22	5.78
Total Income	159.13	197.57	193.21	206.77	190.85	174.44
EXPENDITURE :
Raw Materials	98.53	124.64	126.31	141.72	117.13	103.52
Power & Fuel Cost	14.83	15.40	18.88	14.70	12.36	11.85
Employee Cost	16.35	18.98	16.30	16.33	15.26	13.30
Other Manufacturing Expenses	10.85	14.58	13.66	15.80	13.91	14.60
Selling & Administrative Expenses	9.12	10.93	9.75	8.66	7.65	7.34
Miscellaneous Expenses	1.52	1.16	0.44	0.92	0.64	3.10
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	151.21	185.69	185.35	198.13	166.94	153.71
Operating Profit	7.91	11.88	7.87	8.64	23.91	20.73
Interest	5.19	5.47	3.31	3.10	3.26	3.43
Gross Profit	2.72	6.41	4.56	5.54	20.65	17.30
Depreciation	5.96	5.80	4.47	3.80	3.37	3.21
Profit Before Tax	-3.24	0.61	0.09	1.74	17.28	14.09
Tax	0.00	0.10	0.02	0.29	3.02	2.27
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.95	0.37	0.26	0.31	0.54	0.93
Reported Net Profit	-1.29	0.14	-0.18	1.14	13.72	10.90
Extraordinary Items	0.00	0.00	-0.10	0.00	0.00	0.00
Adjusted Net Profit	-1.29	0.14	-0.08	1.14	13.72	10.90
Adjustment below Net Profit	-1.60	-0.51	0.00	-0.12	-0.14	-0.77
P & L Balance brought forward	34.11	34.49	38.80	38.58	22.47	13.15
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.40	0.80	1.20	0.80
P & L Balance carried down	31.22	34.11	38.21	38.80	34.85	22.47
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	15.00	10.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	1.50	1.00
Earnings Per Share-Unit Curr	-1.33	0.17	-0.23	1.43	17.14	13.62
Earnings Per Share(Adj)-Unit Curr	-1.33	0.17	-0.23	1.43	17.14	13.62
Book Value-Unit Curr	71.00	57.30	57.77	58.50	58.22	42.75
Book Value(Adj)-Unit Curr	71.00	57.30	57.77	58.50	58.22	42.75

83,627.69 -250.48 ( -0.30%)

49,609.72 84.64 (0.17%)

6,998.08 10.80 (0.15%)

53,586.32 1,646.43 (3.17%)

10,138.60 -2.10 (-0.02%)

90.22 0.30 (0.34%)

104.95 0.05 (0.04%)

120.87 0.01 (0.01%)

0.57 0.00 (-0.40%)